5 ASX 200 shares with 33% to 61% upside post-results: experts

As earnings season comes to a close, here are the new 12-month price targets from the experts.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

S&P/ASX 200 Index (ASX: XJO) shares are up 0.03% at 9,095.2 points on the final day of reporting season.

Hundreds of companies have revealed their earnings this season.

Brokers have reviewed the reports and updated their ratings and 12-month price targets accordingly.

Here are five buy-rated ASX 200 shares with significant upside potential ahead, according to the experts.

Hand stacking increasing piles of rocks.

Image source: Getty Images

NextDC Ltd (ASX: NXT)

The NextDC share price is $13.63, down 1.7% today and down 17% over 12 months.

UBS renewed its buy rating on NextDC shares, with a $22.55 target after reviewing the company's FY26 earnings.

This implies potential capital growth of 61% over the next year.

WiseTech Global Ltd (ASX: WTC)

The WiseTech share price is $41.39, up 1.9% today and down 58% over 12 months.

Morgans reiterated its buy rating on this ASX 200 tech share after the company's FY26 results.

The broker reduced its 12-month price target from $67 to $62.50.

However, this still implies a healthy potential upside of 52%.

Droneshield Ltd (ASX: DRO)

The Droneshield share price is $1.74, down 0.7% today and down 46% over 12 months.

Bell Potter renewed its buy rating on this ASX 200 industrials share after its 1H FY26 results.

The broker trimmed its 12-month price target from $2.50 to $2.40.

This suggests a potential 35% upside ahead.

Qantas Airways Ltd (ASX: QAN)

The Qantas share price is $9.56, down 0.3% today and down 17% over 12 months. 

Morgan Stanley kept its buy call in place on Qantas shares following the airline's FY26 results.

The broker raised its target on the ASX 200 industrials share from $12.50 to $12.80.

This suggests a potential 33% upside ahead.

Objective Corporation Ltd (ASX: OCL)

The Objective Corporation share price is $6.40, down 5.9% today and down 69% over 12 months. 

Morgans maintained its buy recommendation on this ASX 200 tech share after the company's FY26 results.

The broker has a revised 12-month price target of $8.50, implying a potential 33% upside ahead.

OCL's FY26 result was largely in line with expectations. The result came however with more sticker shock in the form of another legacy contract loss leading to a further $3.2m ARR reduction.

OCL enters FY27 with ARR of $114.1m. Despite this softening & FX headwinds during the year, OCL continued to see strong underlying SaaS growth momentum and progress of a number of strategic milestones (including the launch of Build Australia), which is key to ARR momentum and FY27+ outlook.

Rebasing our forecasts for OCL's revised FY27 ARR and guidance sees our NPAT estimates reduce by ~18-21% in FY27-28F.

Following these revisions OCL is trading on FY27F P/E of 24x, with a share price near 5 years lows.

Motley Fool contributor Bronwyn Allen has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended DroneShield, Objective, and WiseTech Global. The Motley Fool Australia has positions in and has recommended Objective and WiseTech Global. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

A little girl has a huge smile and a giant lollipop.
Broker Notes

6 ASX shares tipped by brokers to rise 34% to 87%

Post-earnings season, brokers have updated their 12-month price targets on scores of stocks.

Read more »

Happy businessman fist pumping while looking at a tablet.
Broker Notes

2 ASX shares tipped to return 19% to 47%

Recent sell-offs have caught Morgans’ attention, with the broker now rating both shares as buys.

Read more »

Man sitting in a plane looking through a window and working on a laptop.
Broker Notes

Buy, hold, sell: Dicker Data, Polynovo, Flight Centre shares

Here's what the experts think.

Read more »

Two scientists analysing results on a computer screen.
Healthcare Shares

3 ASX healthcare shares to buy with 25% to 100% upside as sector rebound races higher

After slumping to a 9-year low on 3 June, healthcare shares have rallied by an extraordinary 42%.

Read more »

A baby's eyes open wide in surprise as it sucks on a milk bottle.
Broker Notes

How high could Bubs Australia shares go, according to Bell Potter?

A key approval is expected to boost the Bubs share price.

Read more »

a woman in a business suit looks wide eyed and interested as she holds a tin can with string to hear ear listening to some news.
Broker Notes

UBS names its 10 top ASX picks for the next 3-6 months

Here are the 10 ASX shares UBS thinks could outperform.

Read more »

Happy teen friends jumping in front of a wall.
Broker Notes

Guess which ASX stock could rise 85%

Bell Potter sees significant upside from this stock.

Read more »

Buy the dip written on a yellow sign.
Broker Notes

Down 43%! 4 reasons to buy the BIG dip in Pro Medicus shares today

A leading expert believes Pro Medicus shares are well-place to rebound.

Read more »